Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Calcium Carbonate and Thyroxine

Research Papers that Mention the Interaction

Many commonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate , aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine.
Best practice & research. Clinical endocrinology & metabolism  •  2009  |  View Paper
A study of 20 patients receiving long-term levothyroxine replacement therapy indicates that calcium carbonate reduces T4 absorption and increases serum thyrotropin levels [5].
The Indian Journal of Pediatrics  •  2019  |  View Paper
PurposeCalcium carbonate was previously shown to interfere with l-thyroxine absorption.
Endocrine  •  2018  |  View Paper
A decrease in the absorption of LT4 is established and clinically significant when administered concomitantly with cholestyramine, colesevelam, lanthanum, calcium carbonate , calcium citrate, calcium acetate, iron sulfate, ciprofloxacin, aluminum hydroxide, sevelamer, or proton pump inhibitors.
Clinical therapeutics  •  2017  |  View Paper
Furthermore, soy products and several drugs, such as calcium carbonate , bile acid sequestrants, proton pump inhibitors, and ferrous sulfate, may alter L-T4 absorption [7].
Endocrine  •  2016  |  View Paper
BACKGROUND Calcium carbonate is a commonly used dietary supplement and has been shown to interfere with levothyroxine absorption.
Thyroid : official journal of the American Thyroid Association  •  2011  |  View Paper
Sevelamer was also found to be associated with significantly higher dosing requirement of thyroid replacement than those on either calcium carbonate or calcium acetate (Z = −3.17, P = 0.001).ConclusionSevelamer (but not calcium acetate) in addition to calcium carbonate appears to interfere with the bioavailability of levothyroxine.
International Urology and Nephrology  •  2006  |  View Paper
After taking a high dose of calcium carbonate (1250 mg three × daily) with levothyroxine , she developed biochemical evidence of hypothyroidism (thyrotropin up to 41.4 mU/L) while remaining clinically euthyroid.
CONCLUSIONS: Decreased absorption of levothyroxine when given with calcium carbonate may be particularly pronounced in patients with preexisting malabsorption disorders.
DISCUSSION: Concomitant administration of levothyroxine and calcium carbonate often results in levothyroxine malabsorption.
OBJECTIVE: To describe a patient with primary hypothyroidism in whom ingestion of levothyroxine with calcium carbonate led to markedly elevated serum thyrotropin concentrations.
The Annals of pharmacotherapy  •  2001  |  View Paper
When levothyroxine was coadministered with 2.0 g of calcium (as calcium carbonate ), the maximum average T4 absorption decreased to 579 microg (57.9% of the dose ingested) at 240 minutes.
Thyroid : official journal of the American Thyroid Association  •  2001  |  View Paper
Show More